Journal issues
Contents
Free online sample copy
E-mail alert
Register
Search

Editorial
Editor
Instructions to authors
Scope
Audience
Related journals
Indexed in
Supplement enquiry

Customer services
Subscribe
Sample copy
Reprint request
Permissions
Contacts
News
Help

Journal home

Prostate Cancer
and Prostatic Diseases

Scope

Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management.

Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance.

Prostate Cancer covers the following topics:

Alternative therapies Angiogenesis Anti-sense oligonucleotides against growth factors Brachytherapy Conformal radiotherapy Cryotherapy Cyclotron fast neutron treatment Enhancing the results of radical prostatectomy Familial prostate cancer Free to total PSA Gene therapy for prostate cancer Genetic basis for prostate cancer Hormone-related disease How significant is PSA-detected disease? Intermittent antiandrogen therapy Mechanisms of tumour invasion in prostate cancer Medical therapies for BPH Medical therapy for BPH: the road ahead Nutrition in prostate cancer

Photodynamic therapy Prognostic markers Prostate cancer and potency and impotence Prostatic intra-epithelial neoplasia – an important precursor of cancer Prostatitis: quo vadis? Quality of life issues Racial issues in prostate cancer Recurrence after radical prostatectomy Reproducibility (test-retest reliability) of investigations for prostatic diseases Reverse transcriptase polymerase chain reaction to detect circulating mRNA for PSA Role of differentiation therapy Screening for prostate cancer Staging of prostate cancer: beyond conventional imaging The magic bullet – use of PSA promotor gene to target gene therapy Utility of ultrasensitive PSA assays

Last Updated 4 January 2001